Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More
Xconomy
OCTOBER 28, 2016
—As the North American Cystic Fibrosis Conference kicked off in Orlando, FL, Vertex Pharmaceuticals (NASDAQ: VRTX ) said a key part of its plan to defend its industry-leading cystic fibrosis franchise is moving forward. THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases.
Let's personalize your content